Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children
1 other identifier
observational
100
1 country
1
Brief Summary
Diagnosing acute appendicitis in children remains a clinical challenge, with delayed or incorrect diagnosis potentially leading to serious complications or unnecessary surgery. Prostaglandin E urinary metabolites (PGE-M) have been found elevated in various inflammatory conditions, but their diagnostic value in pediatric appendicitis is not well established. This study aims to assess the potential of PGE-M as a biomarker for acute appendicitis in children. The study will be conducted over 12 months and will include 100 children aged 5 to 17 years presenting with acute abdominal pain. In addition to routine laboratory tests, urinary PGE-M levels will be analyzed. The study involves minimal risk to participants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2025
CompletedStudy Start
First participant enrolled
June 2, 2025
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedJune 6, 2025
May 1, 2025
11 months
May 29, 2025
May 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PGE-M
Levels of prostaglandin E urinary metabolite as measured with ELISA test
72 hours
Study Arms (3)
Acute appendicitis with rupture
Acute appendicitis without rupture
Control group
Patients with abdominal pain in which acute appendicitis has been ruled out as a cause
Interventions
Blood specimen collection for analysis of C-reactive protein, white blood cell count and neutrophile count.
Urine sample collection for analysis of creatinine and prostaglandin E urinary metabolites
Eligibility Criteria
Patients from 5 to 17 years of age, presenting with acute abdominal pain consistent with diagnosis of acute appendicitis, to Emergency Surgical Department at the University Hospital of Split
You may qualify if:
- children of age 5 -17 years with acute abdominal pain
- children with clinical signs of acute appendicitis
You may not qualify if:
- previous diagnosis of chronic and/or malignant disease
- children who had previous abdominal surgery
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KBC Splitlead
Study Sites (1)
University Hospital of Split
Split, 21000, Croatia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor of Medicine, Plastic surgery resident
Study Record Dates
First Submitted
May 29, 2025
First Posted
June 6, 2025
Study Start
June 2, 2025
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
June 6, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share